Harvard Medical School (HMS) is the medical school of Harvard University and is located in the Longwood Medical Area in Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools in the United States. Harvard Medical School (HMS) provides patient care, medical education, and research training through its 15 clinical affiliates and research institutes such as Massachusetts General Hospital (MGH), Dana–Farber Cancer Institute, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Boston Children's Hospital, McLean Hospital, Cambridge Health Alliance, The Baker Center for Children and Families, and Spaulding Rehabilitation Hospital. Harvard Medical School also partners with newer entities such as Harvard Catalyst, Broad Institute of MIT and Harvard, Harvard Stem Cell Institute, the Center for Primary Care, and Wyss Institute for Biologically Inspired Engineering.
Massachusetts General Hospital is a teaching hospital located in the West End neighborhood of Boston, Massachusetts. It is the original and largest clinical learning facility of Harvard Medical School, and houses the world's largest hospital-based research program with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts.
Moses Judah Folkman was an American biologist and pediatric surgeon best known for his research on tumor angiogenesis, the process by which a tumor attracts blood vessels to nourish itself and sustain its existence. He founded the field of angiogenesis research, which has led to the discovery of a number of therapies based on inhibiting or stimulating neovascularization.
National Institutes of Health Director's Pioneer Award is a research initiative first announced in 2004 designed to support individual scientists' biomedical research. The focus is specifically on "pioneering" research that is highly innovative and has a potential to produce paradigm shifting results. The awards, made annually from the National Institutes of Health common fund, are each worth $500,000 per year, or $2,500,000 for five years.
Soma Weiss was a Hungarian-born American physician.
Charles Alderson Janeway, Jr. (1943–2003) was a noted immunologist who helped create the modern field of innate immunity. A member of the National Academy of Sciences, he held a faculty position at Yale University's Medical School and was an Howard Hughes Medical Institute Investigator.
Victor Joseph Dzau is a Chinese-American doctor and academic. He serves as the President of the United States National Academy of Medicine of the United States National Academy of Sciences. He was previously the president and CEO of Duke University Medical Center.
Ronald D. Guttmann MD, FRCPC, FCAHS, was born in Minneapolis, Minnesota in 1936 and received his post secondary school education at the University of Minnesota, receiving a B.A. Magna Cum Laude in 1958, and a B.S. and M.D. degree in 1961. He did his Medical Internship at the University of California San Francisco, military service in the USNR at the Tissue Bank, National Naval Medical Center, Bethesda, Medical Residency on the II & IV (Harvard) Medical Service at Boston City Hospital, and a Research & Clinical Fellowship at the Peter Bent Brigham Hospital(now Brigham & Women's Hospital) and Harvard Medical School. In 1969, he was appointed associate in medicine at the Peter Bent Brigham Hospital and instructor in medicine at Harvard Medical School, and permanently moved to Montreal, Canada in 1970 to become director of the transplantation service at the Royal Victoria Hospital and McGill University Clinic and associate professor of medicine, McGill University Faculty of Medicine. During his academic career he directed an active basic and clinical research laboratory program focused on transplantation immunobiology, immunogenetics, immunosuppression, and long term-complications of transplant patients. He also developed an interest in social and ethical issues of transplantation, organ shortage, and human rights abuses.
Donald E. Ingber is an American cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He is also a member of the American Institute for Medical and Biological Engineering, the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, and the American Academy of Arts and Sciences.
Robert Edward Gross was an American surgeon and a medical researcher. He performed early work in pediatric heart surgery at Boston Children's Hospital. Gross was president of the American Association for Thoracic Surgery, a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences.
Atul J. Butte is a biomedical informatics researcher and biotechnology entrepreneur. He is currently the Priscilla Chan and Mark Zuckerberg Distinguished Professor at the University of California, San Francisco. Since April 2015, Butte has serves as inaugural director of UCSF's Bakar Computational Health Sciences Institute.
Andrew D. Luster is the Persis, Cyrus and Marlow B. Harrison Professor of Medicine at Harvard Medical School, and the Chief of the Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital. He is Director of its Research Center for Immunology and Inflammatory Diseases, and a member of the Dana-Farber/Harvard Cancer Center's Cancer Immunology program.
Elazer R. Edelman is an American engineer, scientist and cardiologist. He is the Edward J. Poitras Professor in Medical Engineering and Science at the Massachusetts Institute of Technology (MIT), Professor of Medicine at Harvard Medical School and at Brigham and Women's Hospital (BWH), and a practicing cardiologist at BWH. He is the director of MIT's Institute for Medical Engineering and Science (IMES), the Harvard-MIT Biomedical Engineering Center, and the MIT Clinical Research Center. He is also the Program Director of the MIT Graduate Education in Medical Sciences program within the Harvard-MIT Division of Health Sciences and Technology.
Jochen Reiser is a physician-scientist and a healthcare leader. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System, which includes the oldest Medical School and Nursing School in the state of Texas. As Chief Executive Officer, he oversees the enterprise which includes multiple campuses, five health science colleges, the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas. Before UTMB, he served as the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center. Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Reiser discovered the role of suPAR as a global, circulating risk factor for chronic kidney disease (CKD) and for acute kidney injury (AKI).
Lucila Ohno-Machado is a biomedical engineer and Deputy Dean for Biomedical Informatics at the Yale University School of Medicine. She is an elected member of the American Society for Clinical Investigation and the National Academy of Medicine.
Patricia Kilroy Donahoe is an American pediatric surgeon and a leading researcher in the field of developmental biology and oncology. She was the president of the American Pediatric Surgical Association from 2006 to 2007. She currently serves as the director of pediatric surgical research laboratories and chief emerita of pediatric surgical services at Massachusetts General Hospital.
Jean Elise Schaffer is an American physician-scientist. She is a Senior Investigator at the Joslin Diabetes Center, where she also serves as Associate Research Director, and she is Professor of Medicine at Harvard Medical School. Her work focuses on fundamental mechanisms of metabolic stress responses and the pathophysiology of diabetes complications.
Roy S. Herbst is an American oncologist who is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.
Dennis J. Selkoe is an American physician (neurologist) known for his research into the molecular basis of Alzheimer's disease. In 1985 he became Co-Director of the Center for Neurological Diseases and from 1990, Vincent and Stella Coates Professor of Neurological Diseases at Harvard Medical School. He is also a Fellow of the AAAS and a member of the National Academy of Medicine.
Andrea Lynn Richardson is an American pathologist and physician-scientist specialized in the molecular pathology of breast cancer. She is the Peter and Judy Kovler Professor in Breast Cancer Research and an associate professor of pathology and oncology at the Johns Hopkins School of Medicine. Richardson runs a clinic at the Sibley Memorial Hospital.
